Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
about
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Nanotechnology: Future of OncotherapyCationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigensRole of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide.The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.Improved antigen cross-presentation by polyethyleneimine-based nanoparticles.Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.Lipid Nanoparticles with Accessible Nickel as a Vaccine Delivery System for Single and Multiple His-tagged HIV Antigens.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensNanoparticle-based vaccine delivery for cancer immunotherapy.Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-κB and inflammasomes in macrophages for adjuvant activity.Chitosan-based systems for the delivery of vaccine antigens.Mucosal Vaccine Development Based on Liposome Technology.Synthetic vehicles for DNA vaccination.Cationic liposomes as vaccine adjuvants.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Particle platforms for cancer immunotherapy.VLPs and particle strategies for cancer vaccines.Phagocyte NADPH oxidase and specific immunity.Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.Potential applications of nanoparticles in cancer immunotherapy.Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor LicofelonemRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
P2860
Q26748776-58AE89D4-CBBF-4EC3-8E6B-0EFA91266696Q26801067-A3C52827-BF7F-46E8-9C07-8D825E54A421Q27310007-DE03E1FF-BE3E-4E58-850E-7D674A7B52DDQ33552201-6B662CC3-0BDB-4B2D-9C3A-8F77C931D8C5Q33737612-FC92B54D-194B-47C7-B8E5-342B2B10DADFQ33912706-90E5C02D-C719-45AA-9397-EA12BD5C4B19Q34258873-F91B8B4F-2586-4880-ABFC-E599DED364B4Q34513978-4E125140-858B-4BFA-B395-741BEFCD795CQ34871801-879038A9-30F8-41A6-AE4D-DF1F23225967Q35237737-8CB0D797-CA2C-4B89-8403-F265BF499DBBQ35812875-BC06F033-78D3-4F3D-B60D-12DACC063A65Q37279161-A431A9CD-EE2B-4266-9472-3BEF0B7FCE62Q37390867-53EC4A8A-3F4F-45D7-8D55-F4F8DC12569DQ37501222-5A659CDD-E7C5-4170-9BA4-00CCD842B5BBQ37524050-17728149-B6D7-444D-8ABB-A7B11CA073B6Q37581129-FBBA926A-8D38-42DB-89C8-C31E4236732BQ37611034-419FEE4B-B18E-4EDD-A58F-0C3ACE482A9BQ37867105-1124AC59-0E78-4EFC-86BE-D0B6B63E6D0EQ38028994-81FB40B8-45D6-44A8-85D2-1373C84CC18DQ38068245-3BD5C1A2-FC2D-4415-817D-1499549F806BQ38114060-A7880D03-74DD-4F10-ACC0-327FBC0E88B6Q38152475-1F681B02-0DA1-4A75-8460-AC9FB296DE91Q38373915-70D1D366-E6CA-4ABB-AADA-D64F9476828FQ38811957-D8F84644-EA49-4D15-A8A9-529404357FE9Q38838467-BD4DC13C-5B98-44D8-B827-E4C0059690A5Q39015434-293266B7-2C96-4CCA-979D-34C5D5BD32AFQ42358876-58F4EACF-A0AF-413F-82F6-2760E672C01CQ49715007-B993BB8C-81F2-4C00-8F59-B92BE103F039Q52746279-E8012CB5-56E8-4102-9162-7E889AB162BD
P2860
Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Reactive oxygen species play a ...... liposome based cancer vaccine.
@en
Reactive oxygen species play a ...... liposome based cancer vaccine.
@nl
type
label
Reactive oxygen species play a ...... liposome based cancer vaccine.
@en
Reactive oxygen species play a ...... liposome based cancer vaccine.
@nl
prefLabel
Reactive oxygen species play a ...... liposome based cancer vaccine.
@en
Reactive oxygen species play a ...... liposome based cancer vaccine.
@nl
P2093
P1476
Reactive oxygen species play a ...... liposome based cancer vaccine.
@en
P2093
Leaf Huang
Weihsu Chen
P356
10.1016/J.JCONREL.2008.05.005
P407
P577
2008-05-15T00:00:00Z